Amalgamated Bank Cardiovascular Systems Inc Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$13.31 - $19.86 $15,865 - $23,673	-1,192 Reduced 6.16%	18,157 $361,000
Q4 2022 Feb 10, 2023	BUY	$12.74 - $15.12 $4,611 - $5,473	362 Added 1.91%	19,349 $264,000
Q3 2022 Nov 09, 2022	BUY	$12.93 - $17.17 $1,655 - $2,197	128 Added 0.68%	18,987 $263,000
Q2 2022 Aug 15, 2022	SELL	$13.53 - $23.34 $10,526 - $18,158	-778 Reduced 3.96%	18,859 $271,000
Q1 2022 Jun 30, 2022	SELL	$16.14 - $22.6 $19,206 - $26,894	-1,190 Reduced 5.71%	19,637 $444,000
Q4 2021 Feb 15, 2022	SELL	$18.64 - $36.77 $7,027 - $13,862	-377 Reduced 1.78%	20,827 $391,000
Q3 2021 Oct 29, 2021	SELL	$32.83 - $43.0 $14,084 - $18,447	-429 Reduced 1.98%	21,204 $696,000
Q2 2021 Aug 16, 2021	BUY	$34.41 - $44.03 $540,271 - $691,315	15,701 Added 264.68%	21,633 $923,000
Q1 2021 May 13, 2021	SELL	$37.29 - $47.19 $20,733 - $26,237	-556 Reduced 8.57%	5,932 $227,000
Q4 2020 Feb 12, 2021	BUY	$34.3 - $44.09 $6,482 - $8,333	189 Added 3.0%	6,488 $283,000
Q3 2020 Oct 30, 2020	BUY	$27.86 - $39.35 $175,490 - $247,865	6,299 New	6,299 $248,000
Q2 2020 Aug 10, 2020	SELL	$30.3 - $42.55 $195,859 - $275,043	-6,464 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$30.0 - $54.18 $6,870 - $12,407	-229 Reduced 3.42%	6,464 $228,000
Q4 2019 Feb 13, 2020	BUY	$42.29 - $52.2 $13,532 - $16,704	320 Added 5.02%	6,693 $325,000
Q3 2019 Nov 13, 2019	SELL	$42.06 - $51.64 $4,542 - $5,577	-108 Reduced 1.67%	6,373 $303,000
Q2 2019 Aug 14, 2019	BUY	$33.93 - $43.66 $34,371 - $44,227	1,013 Added 18.53%	6,481 $278,000
Q1 2019 May 15, 2019	BUY	$26.74 - $41.32 $146,214 - $225,937	5,468 New	5,468 $211,000

Others Institutions Holding CSII

# of Institutions

Shares Held

35.5K

Call Options Held

Put Options Held

View Full List

About Cardiovascular Systems Inc

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

More about CSII

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account